Our results provide the molecular background of TRH and TAL effects depending on the amount of β-arrestin2 in cells of the nervous system, which should be taken into account when thinking about potential neuroprotective effects of these ligands in the treatment of neurodegenerative diseases. Here, TRH is linked to neurodegenerative disease.